ELF4 Expression is Associated with Worse Disease Outcomes and Increased Resistance to Anticancer Agents in Human Cancers
Doris Kafita, Victor Daka, Panji Nkhoma, Mildred Zulu, Ephraim Zulu, Rabecca Tembo, Zifa Ngwira, Florence Mwaba, Musalula Sinkala, Sody Mweetwa Munsaka
The paper investigates ELF4 expression in human cancers, finding it correlates with worse outcomes and drug resistance across 32 cancer types.
PLoS ONE · Apr 9, 2021Peer-reviewedGenetic & Genomic Medicine